Avidity Biosciences’ $300 Million Common Stock Offering

Marco Zingaro North America Legal Chronicle
Tagged:

Latham & Watkins advised Avidity Biosciences on the deal, and Wilson Sonsini Goodrich & Rosati acted as patent counsel to Avidity.Avidity Biosciences, Inc. (Nasdaq: RNA), a…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Marco Zingaro

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here